RFS and OS in the study cohort did not significantly differ between IDH1/2wildtype and IDH1mutated or IDH2mutated or pooled IDH1/2mutated AML patients (Fig. 1 and Table S2 in the Data Supplement). Here, IDH1 is linked to acute myeloid leukemia.